Research shows genetic factors increase risk of visceral leishmaniasis

NewsGuard 100/100 Score

A new study published in Nature Genetics last week shows that genetics likely influence whether an individual develops visceral leishmaniasis, a lethal form of the parasitic disease transmitted by sandflies, the New York Times reports. In 80 percent of cases, leishmaniasis causes painful skin boils, but in 20 percent of cases, the disease -- also called kala azar -- spreads to the organs and is fatal if untreated, the newspaper notes. Researchers "compared DNA in almost 6,000 blood samples from India and Brazil," and they found "[b]oth Indians and Brazilians who got visceral leishmaniasis had similar DNA variations," the New York Times writes (McNeil, 1/14). A University of Western Australia press release says the discovery brings researchers "a step closer to developing a vaccine." The press release notes, "Leishmaniasis affects 12 million people and there are an estimated 1.5 million new cases annually mainly in India, Bangladesh, Nepal, Sudan, South Sudan, Ethiopia, and Brazil" (1/8).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Enhancer-gene mapping with SCENT method offers insights into disease mechanisms